A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Celgene
Icahn School of Medicine at Mount Sinai
City of Hope Medical Center
University of Wisconsin, Madison
University of Wisconsin, Madison
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Oncotherapeutics
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center